Table 1.
Association between regulator of G protein signaling 4 expression and clinicopathological characteristics of patients with gastric cancer
|
Characteristics
|
RGS4 expression
|
P value
|
|
|
Low group (n = 45)
|
High group (n = 45)
|
||
| Age, median (IQR) | 64 (60, 68) | 66 (61, 70) | 0.199 |
| Gender, n (%) | 0.806 | ||
| Female | 12 (13.3) | 10 (11.1) | |
| Male | 33 (36.7) | 35 (38.9) | |
| T stage, n (%) | 0.011 | ||
| T1 | 9 (10) | 1 (1.1) | |
| T2 | 9 (10) | 4 (4.4) | |
| T3 | 7 (7.8) | 10 (11.1) | |
| T4 | 20 (22.2) | 30 (33.3) | |
| N stage, n (%) | 0.038 | ||
| N0 | 21 (23.3) | 11 (12.2) | |
| N1 | 10 (11.1) | 9 (10) | |
| N2 | 6 (6.7) | 5 (5.6) | |
| N3 | 8 (8.9) | 20 (22.2) | |
| M stage, n (%) | 1.000 | ||
| M0 | 43 (47.8) | 42 (46.7) | |
| M1 | 2 (2.2) | 3 (3.3) | |
| Grade, n (%) | 0.002 | ||
| G1 | 16 (17.8) | 6 (6.7) | |
| G2 | 18 (20) | 12 (13.3) | |
| G3 | 11 (12.2) | 27 (30) | |
| TNM stage, n (%) | 0.011 | ||
| Stage I | 15 (16.7) | 3 (3.3) | |
| Stage II | 11 (12.2) | 12 (13.3) | |
| Stage III | 17 (18.9) | 27 (30) | |
| Stage IV | 2 (2.2) | 3 (3.3) | |
| OS (month) | |||
| Median (range) | 28 (7-70) | 19 (3-56) | 0.004 |
RGS4: Regulator of G protein signaling 4; IQR: Interquartile range; TNM: Tumor-node-metastasis; OS: Overall survival.